DBDonald L. Boyer

Donald L. Boyer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Donald L. Boyer has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Validity Evidence for the Competency-Based Leadership Assessment Resource (CLAR) Tool in Assessing Pediatric Fellows

    by Angela S. Czaja, Alan Schwartz, Donald L. Boyer, Michael L. Green, Adrian D. Zurca, Tensing Maa, Jason A. Werner, David A. Turner, Mary E. Moffatt, Vanessa McFadden, et al.

  • Validity Evidence for a Transport Medical Control Assessment Tool Using Simulated Interfacility Transport Calls

    by Ryan J. Good, Alan Schwartz, Richard Mink, Donald L. Boyer, Ranna A. Rozenfeld, Rudy J. Kink, Franscesca Miquel-Verges, Courtney K. McLean, Sandeep K. Chilakala, Mark H. Corden, et al.

  • Open Access

    Into the Unknown: Characterizing Fellow Uncertainty During the Transition to Unsupervised Practice

    by Daniel Herchline, Md Margot E. Cohen, Md Marietta Ambrose, Jennifer Hwang, Daniel Kaminstein, Md Marissa Kilberg, Samuel Rosenblatt, Justin Ziemba, Donald Boyer

    Background: Helping fellows confront and manage uncertainty in the course of diagnosis and treatment of patients has been a growing focus of medical education. How these same fellows confront uncertainty as they make a transition in their professional development is less commonly a focus of training programs. Better understanding of how fellows experience these transitions will allow fellows, training programs, and hiring institutions to navigate transitions more easily. Objective: This study aimed to explore how fellows in the United States experience uncertainty during the transition to unsupervised practice. Methods: Using constructivist grounded theory, we invited participants to engage in semi-structured interviews exploring experiences with uncertainty as they navigate the transition to unsupervised practice. Between September 2020 and March 2021, we interviewed 18 physicians in their final year of fellowship training from 2 large academic institutions. Participants were recruited from adult and pediatric subspecialties. Data analysis was conducted using an inductive coding approach. Results: Experiences with uncertainty during the transition process were individualized and dynamic. Primary sources of uncertainty identified included clinical competence, employment prospects, and career vision. Participants discussed multiple strategies for mitigating uncertainty, including structured graduated autonomy, leveraging professional networks locally and non-locally, and utilizing established program and institutional supports. Conclusions: Fellows' experiences with uncertainty during their transitions to unsupervised practice are individualized, contextual, and dynamic with several shared overarching themes.


  • Open Access

    Performance of ChatGPT on the MCAT: The Road to Personalized and Equitable Premedical Learning

    by Vikas L Bommineni, Sanaea Bhagwagar, Daniel Balcarcel, Christos Davatzikos, Donald Boyer

    Despite an increasingly diverse population, an unmet demand for undergraduates from underrepresented racial and ethnic minority (URM) backgrounds exists in the field of medicine as a result of financial hurdles and insufficient educational support faced by URM students in the premedical journey. With the capacity to provide highly individualized and accessible no- or low-cost dynamic instruction, large language models (LLMs) and their chatbot derivatives are posed to change this dynamic and subsequently help shape a more diverse future physician workforce. While studies have established the passing performance and insightful explanations of one of the most accurate LLM-powered chatbots to date—Chat Generative Pre-trained Transformer (ChatGPT)—on standardized exams such as medical licensing exams, the role of ChatGPT in premedical education remains unknown. We evaluated the performance of ChatGPT on the Medical College Admission Test (MCAT), a standardized 230-question multiple choice exam that assesses a broad range of competencies in the natural, physical, social, and behavioral sciences as well as critical analysis and reasoning. Depending on its visual item response strategy, ChatGPT performed at or above the median performance of 276,779 student test takers on the MCAT. Additionally, ChatGPT-generated answers demonstrated both a high level of agreement with the official answer key as well as insight into its explanations. Based on these promising results, we anticipate two primary applications of ChatGPT and future LLM iterations in premedical education: firstly, such models could provide free or low-cost access to personalized and insightful explanations of MCAT competency-related questions to help students from all socioeconomic and URM backgrounds. Secondly, these models could be used to generate additional test questions by test-makers or for targeted preparation by pre-medical students. These applications of ChatGPT in premedical education could be an invaluable, innovative path forward to increase diversity and improve equity among premedical students.


  • List of Contributors

    by Adam C. Adler, Aditee P. Ambardekar, Naomi Balamuth, Alexandra Berman, Tarun Bhalla, Donald L. Boyer, Andrew J. Costandi, C. Hunter Daigle, Gregory Dodson, Jeffrey M. Feldman, et al.

  • The Critically Ill Child

    by Samuel Rosenblatt, C. Hunter Daigle, Donald Boyer

  • Validity Evidence for a Novel, Comprehensive Bag–Mask Ventilation Assessment Tool

    by Allison M. Whalen, Matthew H. Merves, Priyanka Kharayat, James S. Barry, Kristen M. Glass, Robert A. Berg, Taylor Sawyer, Vinay Nadkarni, Donald L. Boyer, Akira Nishisaki


  • Open Access

    Vecuronium- and Esmolol-Induced Pseudohypernatremia Due to Drug Interference With Ion-Selective Electrodes

    by Tracey G. Polsky, Eloise Salmon, Sarah S. Welsh, Derick Ms Lim, Sheng Feng, Lance Ballester, Abdulla M. Ehlayel, Jennifer L. Hewlett, Michelle R. Md Denburg, Donald L. Md Boyer, et al.

    Objectives: We observed that patients treated with continuous vecuronium or esmolol infusions showed elevated plasma sodium measurements when measured by the routine chemistry analyzer as part of the basic metabolic panel (Vitros 5600; Ortho Clinical Diagnostics, Raritan, NJ), but not by blood gas analyzers (RAPIDLab 1265; Siemens, Tarrytown, NY). Both instruments use direct ion-selective electrode technology, albeit with different sodium ionophores (basic metabolic panel: methyl monensin, blood gas: glass). We questioned if the basic metabolic panel hypernatremia represents artefactual pseudohypernatremia. Design: We added vecuronium bromide or esmolol hydrochloric acid to pooled plasma samples and compared sodium values measured by both methodologies. We queried sodium results from the electronic medical records of patients admitted at Children’s Hospital of Philadelphia from 2016 to 2018 and received vecuronium and/or esmolol infusion treatment during their admissions. Setting: PICU of a quaternary, free-standing children’s hospital. Patients: Children admitted to the hospital who received vecuronium and/or esmolol infusion. Measurements and Main Results: Sodium was measured in pooled plasma samples by basic metabolic panel and blood gas methodologies after adding vecuronium bromide or esmolol hydrochloric acid, leading to a dose-response increase in basic metabolic panel sodium measurements. A repeated measures regression analysis of our electronic medical records showed that the vecuronium dose predicted the Δ sodium (basic metabolic panel–blood gas) sodium within 12 hours of the vecuronium administration (p < 0.0018). Esmolol showed a similar trend (p = 0.13). This occurred primarily in central line samples with continuous vecuronium or esmolol infusions. Conclusions: Vecuronium and esmolol can falsely elevate direct ion-selective electrode sodium measurements on Vitros chemistry analyzers. Unexpectedly high sodium measurements in patients receiving vecuronium and/or esmolol infusions should be further investigated with an alternate sample type (i.e., peripheral blood) or measurement methodology (i.e., blood gas) to guide treatment decisions.